Yesterday (June 22) evening, Ali Health released an announcement to disclose the 2016 fiscal year results. In the fiscal year ended March 31, 2016, Ali's health revenue was RMB 56.6 million, an increase of 90.3% year-on-year; the annual loss was RMB 191.6 million, a loss of RMB 81.20 million in the same period of the previous year, of which income mainly came from The drug electronic supervision code business that was previously terminated.
According to the announcement, in the fiscal year 2016, Ali's health sales and marketing expenses were RMB 80.78 million, administrative expenses were RMB 91.79 million, and product development expenditure was RMB 76.15 million.
.jpg)
The announcement also stated that Ali Health has identified three main directions for its business development in the past fiscal year: pharmaceutical e-commerce, medical service network, and medical traceability system.
About future income
Combined with the previous information about Ali Health, the main income of Ali Health Future may come from two aspects:
1) Alibaba Health's exclusive operation of the service fee charged by Tmall Medical Museum. According to the service agreement, Ali Health shall provide Tmall with outsourcing and value-added services including Tmall's medical and health care business investment, customer service and operation. Tmall will pay the service fee to Ali Health. The specific fee is based on the merchant's passing. The sales of Tmall's sales of related products or services accounted for 21.5% of the expenses paid to Tmall. Since the service was launched after the current fiscal year, this earnings report does not include related income.
2) The restarted electronic supervision code service is “reassuring on the codeâ€. At the beginning of this year, due to the lawsuit of Yangtian and Pharmacy to sue the State Food and Drug Administration to shut down China's drug electronic supervision network, in February, the National Bureau issued a document suspending the requirement for the full chain of electronic drugs to cover the electronic supervision code in January last year. Subsequently, Ali Health issued an announcement. Indicates that the transfer of the drug electronic surveillance code business is underway. In April, the National Bureau reissued the "Opinions on Further Improving the Food and Drug Traceability System (Draft for Comment)", and the "Draft for Comment" clarified that "establishing a food and drug traceability system is the main responsibility of enterprises". On May 10, Ali Health Vice President Wang Peiyu revealed that Ali Health decided to build an open, market-oriented third-party traceability platform and continue to use its rich experience and technical capabilities in the field of traceability system construction, with regulatory authorities, pharmaceutical companies, industry organizations, third-party technology service providers. Together with the public, we will build a retrospective ecosystem for anti-counterfeiting drugs. Subsequently, its third-party drug traceability platform will be officially launched.
.jpg)
Although the drug electronic regulatory code business is being recycled, the “code-safe†online line has replaced the vacancy of the drug electronic regulatory code in a timely manner. Previously, the “code-safe†charging standard was exposed, and some insiders estimated that the enterprise The expenditures will increase compared to the previous CFDA's official electronic supervision code. However, due to various reasons of self-built third-party systems, many companies may continue to accept Ali's health.
Other business income, for the time being, there is no prospect of a large profit for the time being.
Steroids Powder name of steroids is adrenocorticosteroids. The adrenal glands of normal people secrete a certain amount of steroids every day to maintain normal physiological functions in the body, such as regulating the metabolism of blood sugar, protein, fat and electrolytes. It is an essential hormone to maintain life.
Steroid is widely distributed in the biological community of a large category of cyclopentane hydrophenanthrene derivatives, also known as steroids, steroids. Steroid compounds do not contain bound fatty acids and are non-saponifiable lipids; These compounds belong to isoprene like substances, which are formed by cyclization of triterpenes through intramolecular reorganization and chemical modification.
raw steroids powder,buy raw steroids powder,raw steroids powder for sale,steroids powder for sale,steroid powder buy
Shaanxi YXchuang Biotechnology Co., Ltd , https://www.peptidenootropic.com